India to Belarus: Efavirenz Export Trade Route

The India to Belarus Efavirenz corridor is one of India's established pharmaceutical export routes, with 11 shipments documented worth a combined $4.3M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 92% of all export value, reflecting the consolidated nature of India's efavirenz manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $389.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with efavirenz's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 11.8%, placing it at rank #2 among India's top efavirenz export destinations globally.

On the import side, key buyers of Indian efavirenz in Belarus include STATE ENTERPRISE ACADEMPHARM, TISHAS ADDITIONAL LIABILITY COMPANY, TO THE ORDER OF and 3 others. STATE ENTERPRISE ACADEMPHARM is the single largest importer with 3 shipments valued at $4.0M USD.

India's efavirenz exports to Belarus are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Belarus benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, MYLAN LABORATORIES LIMITED, HETERO LABS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $389.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as efavir 600 mg tablets (efavirenz) [pac size:1x30x14608 pac=438240 nos] and efavir 600 mg tablets (efavirenz) [pac size:1x30x14346 pac=430380 nos], suggesting that buyers in Belarus tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, STATE ENTERPRISE ACADEMPHARM is the largest importer with 3 shipments worth $4.0M USD — representing 92% of all efavirenz imports from India on this route. A total of 6 buyers are active on this corridor.